NM_001042475.3:c.1020+17269T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001042475.3(CEP85L):​c.1020+17269T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0403 in 152,116 control chromosomes in the GnomAD database, including 198 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.040 ( 198 hom., cov: 32)
Exomes 𝑓: 0.071 ( 0 hom. )

Consequence

CEP85L
NM_001042475.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:5

Conservation

PhyloP100: 1.38

Publications

2 publications found
Variant links:
Genes affected
CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
PLN (HGNC:9080): (phospholamban) The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016]
PLN Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1P
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • intrinsic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 18
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-118548260-A-C is Benign according to our data. Variant chr6-118548260-A-C is described in ClinVar as [Benign]. Clinvar id is 403328.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0585 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP85LNM_001042475.3 linkc.1020+17269T>G intron_variant Intron 3 of 12 ENST00000368491.8 NP_001035940.1 Q5SZL2-1Q3ZCQ5
PLNNM_002667.5 linkc.-230A>C upstream_gene_variant ENST00000357525.6 NP_002658.1 P26678Q5R352

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP85LENST00000368491.8 linkc.1020+17269T>G intron_variant Intron 3 of 12 1 NM_001042475.3 ENSP00000357477.3 Q5SZL2-1
PLNENST00000357525.6 linkc.-230A>C upstream_gene_variant 1 NM_002667.5 ENSP00000350132.5 P26678

Frequencies

GnomAD3 genomes
AF:
0.0403
AC:
6130
AN:
151984
Hom.:
199
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00913
Gnomad AMI
AF:
0.0582
Gnomad AMR
AF:
0.0264
Gnomad ASJ
AF:
0.0490
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0160
Gnomad FIN
AF:
0.0852
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0601
Gnomad OTH
AF:
0.0298
GnomAD4 exome
AF:
0.0714
AC:
1
AN:
14
Hom.:
0
Cov.:
0
AF XY:
0.0833
AC XY:
1
AN XY:
12
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0833
AC:
1
AN:
12
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0403
AC:
6128
AN:
152102
Hom.:
198
Cov.:
32
AF XY:
0.0398
AC XY:
2956
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00910
AC:
378
AN:
41538
American (AMR)
AF:
0.0264
AC:
403
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0490
AC:
170
AN:
3466
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0160
AC:
77
AN:
4822
European-Finnish (FIN)
AF:
0.0852
AC:
903
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0600
AC:
4078
AN:
67912
Other (OTH)
AF:
0.0294
AC:
62
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
305
611
916
1222
1527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0359
Hom.:
38
Bravo
AF:
0.0348
Asia WGS
AF:
0.0120
AC:
40
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dilated cardiomyopathy 1P Pathogenic:1Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Lissencephaly 10 Benign:2
Nov 02, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 17, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 67/2178=3% -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 18241046, 24037902, 21167350) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
15
DANN
Benign
0.79
PhyloP100
1.4
PromoterAI
-0.010
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77186188; hg19: chr6-118869423; API